"Portsmouth Regional Hospital is one many healthcare facilities in the HCA New Hampshire Network of Care."

During the past decade, Portsmouth Regional Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 21 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 8 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Portsmouth Regional Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "SCRI Development Innovations, LLC" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored and "Harvard Pilgrim Health Care" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Portsmouth Regional Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Centers for Disease Control and Prevention" with 3 trials as a collaborator, "Rush University" with 3 trials as a collaborator, "Amgen" with 2 trials as a collaborator and "Bayer" with 2 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Portsmouth Regional Hospital" are "Breast Cancer" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials), "Metastatic Breast Cancer" (3 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Portsmouth Regional Hospital" in a lesser frequency.

Most popular intervention types in "Portsmouth Regional Hospital" are "Drug" (31 trials), "Other" (23 trials), "Biological" (11 trials), "Procedure" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Paclitaxel" (6 trials), "Bevacizumab" (5 trials), "Carboplatin" (5 trials) and "Quality-of-Life Assessment" (5 trials). Other intervention names were less common.

The vast majority of trials in "Portsmouth Regional Hospital" are 28 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Portsmouth Regional Hospital". undefined are not yet recruiting, 3 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Portsmouth Regional Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Portsmouth Regional Hospital, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".